Friess Associates’s Amyris Inc. AMRS Stock Holding History

Friess Associates’s Portfolio AMRS Stock Details AMRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-105,000	Closed	-$307K	–	137
2020 Q3	$307K	Buy	+105,000	New	+$385K	0.03%	104

Other funds holding AMRS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

TCM

Tanaka Capital Management New York $59.9M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Friess Associates's AMRS Position: Q4 2020 in Review

Friess Associates sold out of Amyris Inc. (AMRS) in Q4 2020, closing a stake of 105,000 shares — an estimated $307K sold.

Friess Associates first reported a position in AMRS in Q3 2020 and held it in 1 quarter. The position peaked at $307K in Q3 2020. 129 funds tracked by Wall St. Rank hold AMRS as of Q4 2020.

Friess Associates reported no remaining Amyris Inc. position as of Q4 2020 after selling out during the quarter.
Friess Associates sold 105,000 Amyris Inc. shares in Q4 2020, an estimated $307K.
Friess Associates first reported a position in Amyris Inc. in Q3 2020 and held it in 1 quarter.
Friess Associates's Amyris Inc. position peaked at $307K in Q3 2020.
129 funds tracked by Wall St. Rank held Amyris Inc. as of Q4 2020.

Based on Friess Associates's 13F filing for Q4 2020, filed 12 Feb 2021.